Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Number of employees : 134 500 people.
Sales per Business
20192020Delta
Pharmaceutical42 198.0051.4%45 572.0055.2% +8%
Medical Devices25 963.0031.6%22 959.0027.8% -11.57%
Consumer13 898.0016.9%14 053.0017% +1.12%
USD in Million
Sales per region
20192020Delta
United States42 097.0051.3%43 133.0052.2% +2.46%
Europe18 466.0022.5%18 980.0023% +2.78%
Asia-Pacific, Africa15 555.0018.9%15 136.0018.3% -2.69%
Western Hemisphere Excluding United States5 941.007.2%5 335.006.5% -10.2%
USD in Million
Managers
Name Title Age Since
Alex Gorsky Chairman & Chief Executive Officer 59 2012
Joseph Wolk Chief Financial Officer & Executive Vice President 53 2018
Paulus Stoffels Chief Scientific Officer 59 2012
James Swanson Global Chief Information Officer & Executive VP - 2019
Charles O. Prince Independent Director 70 2006
Anne M. Mulcahy Lead Independent Director 67 2012
Ronald Williams Independent Director 70 2011
Ian Davis Independent Non-Executive Director 69 2010
A. Eugene Washington, Dr. Independent Director 69 2012
Mark B. McClellan, Dr. Independent Director 56 2013
Members of the board
Name Title Age Since
Alex Gorsky Chairman & Chief Executive Officer 59 2012
Charles O. Prince Independent Director 70 2006
Anne M. Mulcahy Lead Independent Director 67 2012
Ronald Williams Independent Director 70 2011
Ian Davis Independent Non-Executive Director 69 2010
A. Eugene Washington, Dr. Independent Director 69 2012
Mark B. McClellan, Dr. Independent Director 56 2013
D. Davis Independent Director 68 2014
Mary C. Beckerle, Dr. Independent Director 65 2015
Jennifer A. Doudna, Dr. Independent Director 56 2018
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,120,336,092 2,630,336,083 84.3% 487,854,000 15.6% 84.3%
Shareholders
NameEquities%
The Vanguard Group, Inc. 220,690,857 8.38%
SSgA Funds Management, Inc. 142,047,884 5.40%
BlackRock Fund Advisors 59,420,424 2.26%
Geode Capital Management LLC 42,214,232 1.60%
State Farm Investment Management Corp. 34,574,792 1.31%
Wellington Management Co. LLP 32,934,778 1.25%
Capital Research & Management Co. 32,520,000 1.24%
Northern Trust Investments, Inc.(Investment Management) 31,438,505 1.19%
Norges Bank Investment Management 27,770,786 1.05%
Massachusetts Financial Services Co. 27,371,182 1.04%
Holdings
NameEquities%Valuation
CRYO-CELL INTERNATIONAL, INC. (CCEL) 152,882 1.81% 1,773,431 USD
GRAIL, INC. 50,868,671 7.58% 509 USD
IDORSIA LTD (IDIA) 0 0.0000%
Markets and indexes
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Company contact information
Johnson & Johnson
1 Plaza Johnson et Johnson
NJ 08933 New Brunswick, New Jersey

Phone : +1 (732) 524 0400
Fax :
web site : http://www.jnj.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Johnson & Johnson
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
JOHNSON & JOHNSON4.98%434 939
ROCHE HOLDING AG11.70%327 062
PFIZER, INC.19.23%249 329
NOVO NORDISK A/S51.34%233 887
ELI LILLY AND COMPANY36.28%209 456
ABBVIE INC.0.54%190 996
NOVARTIS AG-6.89%188 323
MERCK & CO., INC.-12.37%182 183
ASTRAZENECA PLC11.16%173 735
BRISTOL-MYERS SQUIBB COMPANY-1.16%136 060
AMGEN INC.-4.58%123 428
SANOFI3.77%120 604
GLAXOSMITHKLINE PLC3.95%96 182
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-23.73%61 871
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.54%54 198
BAYER AG-5.22%52 750
DAIICHI SANKYO COMPANY, LIMITED-20.66%48 385
JIANGSU HENGRUI MEDICINE CO., LTD.-49.45%45 545
ASTELLAS PHARMA INC.18.51%31 807
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY47.57%24 385